logo
Pramana Receives Health Canada Authorization for Digital Pathology Scanners

Pramana Receives Health Canada Authorization for Digital Pathology Scanners

Business Wire3 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Pramana, an AI-enabled health tech company modernizing the pathology sector, today announced it has received Health Canada Medical Device Licenses for its flagship digital pathology scanners, the SpectralM and SpectralHT Cubiq systems. The approval authorizes Pramana to import, market, and sell its devices in Canada, expanding access to its advanced imaging and workflow solutions.
Health Canada authorization is required to commercialize Class II medical devices and affirms the product's safety, effectiveness, and quality. The approval opens the door for Pramana to support Canadian hospitals, pathology labs, and research institutions, helping modernize diagnostic workflows with scalable, AI-powered digital pathology tools. This recognition marks a critical step in Pramana's international expansion, building on its growing regulatory footprint.
'Receiving Health Canada authorization is a major milestone in our commercialization strategy,' said Prasanth Perugupalli, Chief Product Officer at Pramana. 'It reflects the strength of our product development, quality, and regulatory readiness, and it opens the door to expanding access to our technology in a market known for strong clinical and academic institutions.'
Pramana's scanners are designed to digitize a wide range of pathology slides, producing high-resolution whole-slide images with automated quality control and AI-powered decision support. The platform supports both FFPE tissue and Liquid Based Cytology (LBC) samples prepared using methods such as the ThinPrep® Pap test (Hologic) and BD SurePath™ (Becton Dickinson). Unlike most digital pathology systems focused solely on anatomic pathology, Pramana expands digital workflows to include hematopathology, microbiology, and cytology, delivering flexibility across all major slide types.
'Our research at the University of Toronto highlights the need for adaptable platforms that can manage these technical demands while still supporting routine histology and cytology workflows,' said Dr. Carlo Hojilla, Consultant Pathologist at the University of Toronto. 'Pramana's technology meets that standard, and its Health Canada authorization reflects both its clinical utility and the rigorous quality required for widespread adoption.'
Prior to receiving Health Canada authorization, Pramana secured Medical Device Single Audit Program (MDSAP) certification, a requirement that validated its quality management system and streamlined regulatory access in Canada, the United States, Brazil, Australia, and Japan, highlighting Pramana's commitment to modernizing digital pathology worldwide.
To discover how Pramana's whole-slide imaging solution can help healthcare organizations across Canada, visit explore.pramana.ai/health-canada.
About Pramana, Inc.
Pramana is a health tech company transforming digital pathology with AI-powered imaging solutions that support seamless adoption across labs, health systems, and medical centers. Pramana's Spectral scanners deliver industry-leading image quality and unprecedented accuracy. Built-in AI algorithms and automated quality control streamline workflows, increase efficiency, and capture previously undetectable tissue features, empowering pathologists with the tools needed to improve clinical diagnostics and research. The company is headquartered in Cambridge, Mass. For more information, visit pramana.ai.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How a major Mexican tomato exporter is affected by Trump's 17% tariff
How a major Mexican tomato exporter is affected by Trump's 17% tariff

Chicago Tribune

time8 hours ago

  • Chicago Tribune

How a major Mexican tomato exporter is affected by Trump's 17% tariff

AJUCHITLAN, Mexico — The Trump administration's decision to impose a 17% duty on fresh tomatoes imported from Mexico has created a dilemma for the country providing more tomatoes to U.S. consumers than any other. The import tax that began July 14 is just the latest protectionist move by an administration that has threatened dozens of countries with tariffs, including its critical trading partner Mexico. It comes as the Mexican government tries to also negotiate its way out of a 30% general tariff scheduled to take effect Aug. 1. While the impacts of the tomato tariff are still in their infancy, a major grower and exporter in central Mexico shows how a tariff targeting a single product can destabilize the sector. Green tomato plants stretch upward row after row in sprawling high-tech greenhouses covering nearly six acres in the central state of Queretaro, among the top 10 tomato producing states in Mexico. Climate controlled and pest free, Veggie Prime's greenhouses in Ajuchitlan send some 100 tons of fresh tomatoes every week to Mastronardi Produce. The Canadian company is the leading distributor of fresh tomatoes in the U.S. with clients that include Costco and Walmart. Moisés Atri, Veggie Prime's export director, says they've been exporting tomatoes to the U.S. for 13 years and their substantial investment and the cost to produce their tomatoes won't allow them to make any immediate changes. They're also contractually obligated to sell everything they produce to Mastronardi until 2026. 'None of us (producers) can afford it,' Atri said. 'We have to approach our client to adjust the prices because we're nowhere near making that kind of profit.' In the tariff's first week, Veggie Prime ate the entire charge. In the second, its share of the new cost lowered when its client agreed to increase the price of their tomatoes by 10%. The 56-year-old Atri hopes that Mastronardi will eventually pass all of the tariff's cost onto its retail clients. Experts say the tariff could cause a 5% to 10% drop in tomato exports, which last year amounted to more than $3 billion for Mexico. The Mexican Association of Tomato Producers says the industry generates some 500,000 jobs. Juan Carlos Anaya, director general of the consulting firm Grupo Consultor de Mercados Agrícolas, said a drop in tomato exports, which last year amounted to more than 2 billion tons, could lead to the loss of some 200,000 jobs When the Trump administration announced the tariff, the Commerce Department justified it as a measure to protect U.S. producers from artificially cheap Mexican imports. California and Florida growers that produce about 11 million tons would stand to benefit most, though most of that production is for processed tomatoes. Experts believe the U.S. would find it difficult to replace Mexico's fresh tomato imports. Atri and other producers are waiting for a scheduled review of the measure in two months, when the U.S. heads into fall and fresh tomato production there begins to decline. In reaction to the tariff, the Mexican government has floated the idea of looking for other, more stable, international markets. Mexican Agriculture Secretary Julio Berdegué said Thursday that the government is looking at possibilities like Japan, but producers quickly cast doubt on that idea, noting the tomatoes would have to be sent by plane, raising the cost even more. Atri said the company is starting to experiment with peppers, to see if they would provide an option at scale. President Claudia Sheinbaum said recently her administration would survey tomato growers to figure out what support they need, especially small producers who are already feeling the effects of a drop of more than 10% in the price of tomatoes domestically over fears there will be a glut in Mexico.

Grow up in the ‘60s or ‘70s? This ‘dangerously high' exposure may have put your brain at risk
Grow up in the ‘60s or ‘70s? This ‘dangerously high' exposure may have put your brain at risk

New York Post

time11 hours ago

  • New York Post

Grow up in the ‘60s or ‘70s? This ‘dangerously high' exposure may have put your brain at risk

Prepare to fume. Leaded gasoline was widely used as car fuel in the US from the 1920s until the 1970s — it was phased out because it was found to be harmful to the environment and human health. It's taken decades for the extent of lead's toxicity to be fully understood. A new study adds to the grim news — if you lived in an area with high levels of atmospheric lead between 1960 and 1974, when leaded gas was at its peak, you're 20% more likely to suffer memory problems later in life. 4 This photo shows cars lining up at a California gas station on Sep. 21, 1973, during peak use of leaded fuel. AP 'Research suggests half the US population — more than 170 million people — were exposed to high lead levels in early childhood,' said Maria C. Carrillo, the Alzheimer's Association's chief science officer and medical affairs lead. 'This research sheds more light on the toxicity of lead related to brain health in older adults today.' Lead was initially added to gas in the early 1920s to improve engine performance and prevent a knocking or rattling sound that occurs when fuel burns unevenly in the engine's cylinders. It was eventually deemed dangerous to the maturing brains and nervous systems of young children, who experienced developmental, learning and behavioral difficulties. 4 Leaded gas was slowly phased out in the US for on-road vehicles before being banned in 1996. This photo is of an NYC gas station circa 1980. Getty Images Adults faced neurological and reproductive issues, and soil and water contamination persisted. The sale of leaded fuel for on-road vehicles was gradually reduced in the US over two decades, with a full ban taking effect in 1996. For the new study, University of Toronto researchers mapped historic atmospheric lead levels in the US. They compared this data to the memory difficulties that more than 600,000 residents 65 and over described from 2012 to 2021. Residents were only included in the analysis if they lived in their birth state. The study authors calculated that 17% to 22% of people in places with moderate, high or extremely high atmospheric lead levels reported memory problems. 'When I was a child in 1976, our blood carried 15 times more lead than children's blood today,' said Esme Fuller-Thomson, senior author of the study and director of the Institute for Life Course and Aging at the University of Toronto. 'An astonishing 88% of us had levels higher than 10 micrograms per deciliter, which are now considered dangerously high.' 4 A new study suggests that if you lived in an area with high levels of atmospheric lead between 1960 and 1974, when leaded gas was at its peak, you're 20% more likely to suffer memory problems later in life. wirojsid – The researchers — who are presenting their work this week at the Alzheimer's Association International Conference (AAIC) in Toronto — recommend that those concerned about decades-old lead exposure focus on reducing other dementia risk factors, such as high blood pressure, smoking and loneliness. Over 6 million Americans have dementia, which gradually destroys memory, concentration and judgment skills. It's responsible for more than 100,000 deaths each year. Unfortunately, there's no easy way to measure long-term lead exposure. Lead levels in the blood primarily reflect recent or ongoing exposure. Lead is stored in the bones for significantly longer than in the blood — but that marker presents challenges. 'Some research studies have measured lead in the bone,' Dr. Eric Brown, lead study author, told The Post. 'This is done by using a technology called K-X-ray fluorescence, however, it is not available to the general public and is primarily a research tool, not a clinical tool.' What's more, leaded gas is still used in some aircraft and race cars — and lead pipes and paint remain a significant public health concern in many areas. 4 This photo from June 2020 shows lead paint chipping off a wall in Clifton, NJ. Christopher Sadowski A separate study shared at AAIC revealed that lead exposure — even at low levels — can contribute to the accumulation of abnormal tau and amyloid beta, proteins associated with Alzheimer's disease, in brain cells. And finally, another AAIC study found that older adults living about 3 miles from a lead-releasing facility — such as glass, ready-mixed concrete or computer and electronics manufacturers — face greater odds of memory and thinking problems than those living farther away. 'Our results indicate that lead exposure in adulthood could contribute to worse cognitive performance within a few years,' said Kathryn Conlon, senior study author and an associate professor of environmental epidemiology at UC Davis. 'Despite tremendous progress on lead abatement,' she added, 'studies have shown there is no safe level of exposure, and half of US children have detectable levels of lead in their blood.'

As Trump's trade deal deadline approaches, his tariffs face legal pushback in court
As Trump's trade deal deadline approaches, his tariffs face legal pushback in court

Hamilton Spectator

time12 hours ago

  • Hamilton Spectator

As Trump's trade deal deadline approaches, his tariffs face legal pushback in court

WASHINGTON - Donald Trump's plan to realign global trade faces its latest legal barrier this week in a federal appeals court — and Canada is bracing for the U.S. president to follow through on his threat to impose higher tariffs. While Trump set an Aug. 1 deadline for countries to make trade deals with the United States, the president's ultimatum has so far resulted in only a handful of frameworks for trade agreements. Deals have been announced for Japan, Vietnam, Indonesia, the Philippines and the United Kingdom — but Trump indicated last week that an agreement with Canada is far from complete. 'We don't have a deal with Canada, we haven't been focused on it,' Trump told reporters Friday. Trump sent a letter to Prime Minister Mark Carney threatening to impose 35 per cent tariffs if Canada doesn't make a trade deal by the deadline. The White House has said those duties would not apply to goods compliant with the Canada-U.S.-Mexico Agreement on trade. Canadian officials have also downplayed expectations of a new economic and security agreement materializing by Friday. 'We'll use all the time that's necessary,' Carney said last week. Countries around the world will also be watching as Trump's use of a national security statute to hit nations with tariffs faces scrutiny in the United States Court of Appeals for the Federal Circuit. The U.S. Court of International Trade ruled in May that Trump does not have the authority to wield tariffs on nearly every country through the use of the International Economic Emergency Powers Act of 1977. The act, usually referred to by the acronym IEEPA, gives the U.S. president authority to control economic transactions after declaring an emergency. No previous president had ever used it for tariffs and the U.S. Constitution gives power over taxes and tariffs to Congress. The Trump administration quickly appealed the lower court's ruling on the so-called 'Liberation Day' and fentanyl-related tariffs and arguments are set to be heard in the appeal court on Thursday. The hearing combines two different cases that were pushing against Trump's tariffs. One involves five American small businesses arguing specifically against Trump's worldwide tariffs, and the other came from 12 states pushing back on both the 'Liberation Day' duties and the fentanyl-related tariffs. George Mason University law professor Ilya Somin called Trump's tariff actions a 'massive power grab.' Somin, along with the Liberty Justice Center, is representing the American small businesses. 'We are hopeful — we can't know for sure obviously — we are hopeful that we will continue to prevail in court,' Somin said. Somin said they are arguing that IEEPA does not 'give the president the power to impose any tariff he wants, on any nation, for any reason, for as long as he wants, whenever he feels like it.' He added that 'the law also says there must be an emergency and an unusual and extraordinary threat to American security or the economy' — and neither the flow of fentanyl from Canada nor a trade deficit meet that definition. U.S. government data shows a minuscule volume of fentanyl is seized at the northern border. The White House has said the Trump administration is legally using powers granted to the executive branch by the Constitution and Congress to address America's 'national emergencies of persistent goods trade deficits and drug trafficking.' There have been 18 amicus briefs — a legal submission from a group that's not party to the action — filed in support of the small businesses and states pushing against Trump's tariffs. Two were filed in support of the Trump administration's actions. Brent Skorup, a legal fellow at the Washington-based Cato Institute, said the Trump administration is taking a vague statute and claiming powers never deployed by a president before. The Cato Institute submitted a brief that argued 'the Constitution specifies that Congress has the power to set tariffs and duties.' Skorup said there are serious issues with the Trump administration's interpretation of IEEPA. 'We don't want power consolidated into a single king or president,' he said. It's expected the appeals court will expedite its ruling. Even if it rules against the duties, however, they may not be immediately lifted. White House Press Secretary Karoline Leavitt has said the Supreme Court should 'put an end to this.' There are at least eight lawsuits challenging the tariffs. Canada is also being hit with tariffs on steel, aluminum and automobiles. Trump used different powers under the Trade Expansion Act of 1962 to enact those duties. This report by The Canadian Press was first published July 27, 2025.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store